Barclays Reiterates Overweight on Braze, Raises Price Target to $50
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Ryan Macwilliams reiterated an Overweight rating on Braze (NASDAQ:BRZE) and raised the price target from $45 to $50.
June 12, 2023 | 12:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Ryan Macwilliams reiterated an Overweight rating on Braze and raised the price target from $45 to $50.
The news of Barclays reiterating an Overweight rating and raising the price target for Braze is positive for the stock. This indicates that the analyst has a bullish outlook on the company and expects its stock price to rise in the short term. As a result, this news is likely to have a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100